Definition
Myocardial infarction (MI) is defined as the death of myocardial cells due to a prolonged time of ischemia (Thygesen et al. 2018). Clinically, the term should be used when acute myocardial injury is detected by abnormal cardiac biomarkers (such as troponins, myoglobin, creatine kinase-MB isoform) in the setting of evidence of acute myocardial ischemia (Thygesen et al. 2018). If there is no conclusive evidence to support the theory of myocardial ischemia but elevated cardiac biomarkers are present, the term myocardial injury should be used according to the latest universal definition of myocardial infarction published in 2018 as a consensus statement of many major cardiovascular societies (Thygesen et al. 2018).
Historically, MI is one of the most severe and furthermore most feared complication of progressive coronary artery disease (CAD). CAD refers to an atherosclerotic process taking place in the...
References
Capodanno D, Gargiulo G, Capranzano P, Mehran R, Tamburino C, Stone GW (2016) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: an updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 5(3):253–262. https://doi.org/10.1177/2048872615572599
Cavender MA, Sabatine MS (2014) Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Lancet 384(9943):599–606. https://doi.org/10.1016/S0140-6736(14)61216-2
Fryar CD, Chen TC, Li X (2012) Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999–2010. NCHS Data Brief (103):1–8
Libby P (2011) Molecular mechanisms of the acute coronary syndromes: the roles of inflammation and immunity. In: Acute Coronary Syndromes: a companion to Braunwald’s heart disease edited by Pierre Theroux. 2nd ed. Saunders, Philadelphia, pp 53–60
Libby P, Pasterkamp G, Crea F, Jang IK (2019) Reassessing the mechanisms of acute coronary syndromes. Circ Res 124(1):150–160. https://doi.org/10.1161/CIRCRESAHA.118.311098
McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ (2011) Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 124(1):40–47. https://doi.org/10.1016/j.amjmed.2010.07.023
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ et al (2016) Executive summary: heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 133(4):447–454. https://doi.org/10.1161/CIR.0000000000000366
Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366(1):54–63. https://doi.org/10.1056/NEJMra1112570
Nichols M, Townsend N, Scarborough P, Rayner M (2013) Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009. Eur Heart J 34(39):3017–3027. https://doi.org/10.1093/eurheartj/eht159
Olivier B-B (2011) Myocardial cell death and regeneration. In: Acute coronary syndromes: a companion to Braunwald’s heart disease edited by Pierre Theroux. 2nd ed. Saunders, Philadelphia, pp 66–80
Ross R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340(2):115–126. https://doi.org/10.1056/NEJM199901143400207
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al (2018) Fourth universal definition of myocardial infarction. Circulation 138(20):e618–ee51. https://doi.org/10.1161/CIR.0000000000000617
Vasile VC, Jaffe AS (2017) High-sensitivity cardiac troponin for the diagnosis of patients with acute coronary syndromes. Curr Cardiol Rep 19(10):92. https://doi.org/10.1007/s11886-017-0904-4
WHO. The top 10 causes of death. 2018
Wilson PW (1994) Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 7(7 Pt 2):7S–12S. https://doi.org/10.1093/ajh/7.7.7s
Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362(23):2155–2165. https://doi.org/10.1056/NEJMoa0908610
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag Berlin Heidelberg New York
About this entry
Cite this entry
Westphal, J.G., Schulze, P.C. (2021). Myocardial Infarction. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_6215-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-21573-6_6215-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21573-6
Online ISBN: 978-3-030-21573-6
eBook Packages: Living Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences